Synthesis of Nano-Paramagnetic Oleuropein to Induce KRAS Over-Expression: A New Mechanism to Inhibit AGS Cancer Cells

Human gastric adenocarcinoma (AGS) is one of the most common malignant cancers worldwide. The present study aimed to transfer oleuropein into cancer cells using synthetic paramagnetic nanoparticles and study their effect on the AGS (ATCC CRL1739™) cell line. Paramagnetic nano-oleuropein was synthesi...

Full description

Saved in:
Bibliographic Details
Published inMedicina (Kaunas, Lithuania) Vol. 55; no. 7; p. 388
Main Authors Barzegar, Farhad, Zaefizadeh, Mohammad, Yari, Reza, Salehzadeh, Ali
Format Journal Article
LanguageEnglish
Published Switzerland MDPI 19.07.2019
MDPI AG
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Human gastric adenocarcinoma (AGS) is one of the most common malignant cancers worldwide. The present study aimed to transfer oleuropein into cancer cells using synthetic paramagnetic nanoparticles and study their effect on the AGS (ATCC CRL1739™) cell line. Paramagnetic nano-oleuropein was synthesized using four-stage co-precipitation by developing NH-connected bridges and was evaluated by EDS, SEM and FTIR methods. Different concentrations of magnetic oleuropein (0, 0.15, 0.45, 1.37, 4.12, 12.35, 37.04, 111.11, 333.33, 1000 µg/mL) were used to treat the AGS cell line in a completely randomized design using a statistical framework with three replicates. The relative expression rate of miR-200 and KRAS oncogenes was evaluated using real-time PCR. The inhibition rate of the AGS cells was assessed using the MTT test at 24, 48 and 72 h intervals. The results showed that there was a significant difference between the inhibition rates of magnetic nano-oleuropein at IC50-24h (23.6 µg/mL), IC50-48h (15.2 µg/mL) and IC50-72h (9.2 µg/mL). Real-time PCR indicated that the relative expression of KRAS and miR-200 genes was highest at IC50 at these intervals. Magnetic nano-oleuropein can be subjected to objective testing and clinical evaluations as a natural antioxidant to prevent and treat gastric adenocarcinoma.
AbstractList Background and objectives: Human gastric adenocarcinoma (AGS) is one of the most common malignant cancers worldwide. The present study aimed to transfer oleuropein into cancer cells using synthetic paramagnetic nanoparticles and study their effect on the AGS (ATCC® CRL1739™) cell line. Materials and Methods: Paramagnetic nano-oleuropein was synthesized using four-stage co-precipitation by developing NH-connected bridges and was evaluated by EDS, SEM and FTIR methods. Different concentrations of magnetic oleuropein (0, 0.15, 0.45, 1.37, 4.12, 12.35, 37.04, 111.11, 333.33, 1000 µg/mL) were used to treat the AGS cell line in a completely randomized design using a statistical framework with three replicates. The relative expression rate of miR-200 and KRAS oncogenes was evaluated using real-time PCR. The inhibition rate of the AGS cells was assessed using the MTT test at 24, 48 and 72 h intervals. Results: The results showed that there was a significant difference between the inhibition rates of magnetic nano-oleuropein at IC50-24h (23.6 µg/mL), IC50-48h (15.2 µg/mL) and IC50-72h (9.2 µg/mL). Real-time PCR indicated that the relative expression of KRAS and miR-200 genes was highest at IC50 at these intervals. Conclusions: Magnetic nano-oleuropein can be subjected to objective testing and clinical evaluations as a natural antioxidant to prevent and treat gastric adenocarcinoma.
Background and objectives: Human gastric adenocarcinoma (AGS) is one of the most common malignant cancers worldwide. The present study aimed to transfer oleuropein into cancer cells using synthetic paramagnetic nanoparticles and study their effect on the AGS (ATCC ® CRL1739™) cell line. Materials and Methods: Paramagnetic nano-oleuropein was synthesized using four-stage co-precipitation by developing NH-connected bridges and was evaluated by EDS, SEM and FTIR methods. Different concentrations of magnetic oleuropein (0, 0.15, 0.45, 1.37, 4.12, 12.35, 37.04, 111.11, 333.33, 1000 µg/mL) were used to treat the AGS cell line in a completely randomized design using a statistical framework with three replicates. The relative expression rate of miR-200 and KRAS oncogenes was evaluated using real-time PCR. The inhibition rate of the AGS cells was assessed using the MTT test at 24, 48 and 72 h intervals. Results: The results showed that there was a significant difference between the inhibition rates of magnetic nano-oleuropein at IC50-24h (23.6 µg/mL), IC50-48h (15.2 µg/mL) and IC50-72h (9.2 µg/mL). Real-time PCR indicated that the relative expression of KRAS and miR-200 genes was highest at IC50 at these intervals. Conclusions: Magnetic nano-oleuropein can be subjected to objective testing and clinical evaluations as a natural antioxidant to prevent and treat gastric adenocarcinoma.
Human gastric adenocarcinoma (AGS) is one of the most common malignant cancers worldwide. The present study aimed to transfer oleuropein into cancer cells using synthetic paramagnetic nanoparticles and study their effect on the AGS (ATCC CRL1739™) cell line. Paramagnetic nano-oleuropein was synthesized using four-stage co-precipitation by developing NH-connected bridges and was evaluated by EDS, SEM and FTIR methods. Different concentrations of magnetic oleuropein (0, 0.15, 0.45, 1.37, 4.12, 12.35, 37.04, 111.11, 333.33, 1000 µg/mL) were used to treat the AGS cell line in a completely randomized design using a statistical framework with three replicates. The relative expression rate of miR-200 and KRAS oncogenes was evaluated using real-time PCR. The inhibition rate of the AGS cells was assessed using the MTT test at 24, 48 and 72 h intervals. The results showed that there was a significant difference between the inhibition rates of magnetic nano-oleuropein at IC50-24h (23.6 µg/mL), IC50-48h (15.2 µg/mL) and IC50-72h (9.2 µg/mL). Real-time PCR indicated that the relative expression of KRAS and miR-200 genes was highest at IC50 at these intervals. Magnetic nano-oleuropein can be subjected to objective testing and clinical evaluations as a natural antioxidant to prevent and treat gastric adenocarcinoma.
Author Zaefizadeh, Mohammad
Yari, Reza
Salehzadeh, Ali
Barzegar, Farhad
AuthorAffiliation 1 Department of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran
3 Department of Biology, Borujerd Branch, Islamic Azad University, Borujerd, Iran
2 Department of Biology, Ardabil Branch, Islamic Azad University, Ardabil, Iran
AuthorAffiliation_xml – name: 1 Department of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran
– name: 2 Department of Biology, Ardabil Branch, Islamic Azad University, Ardabil, Iran
– name: 3 Department of Biology, Borujerd Branch, Islamic Azad University, Borujerd, Iran
Author_xml – sequence: 1
  givenname: Farhad
  surname: Barzegar
  fullname: Barzegar, Farhad
  organization: Department of Biology, Rasht Branch, Islamic Azad University, 31567-56157 Rasht, Iran
– sequence: 2
  givenname: Mohammad
  surname: Zaefizadeh
  fullname: Zaefizadeh, Mohammad
  email: mzaefi@iauardabil.ac.ir
  organization: Department of Biology, Ardabil Branch, Islamic Azad University, 56199-11367 Ardabil, Iran. mzaefi@iauardabil.ac.ir
– sequence: 3
  givenname: Reza
  orcidid: 0000-0003-1604-1889
  surname: Yari
  fullname: Yari, Reza
  organization: Department of Biology, Borujerd Branch, Islamic Azad University, 14676-86831 Borujerd, Iran
– sequence: 4
  givenname: Ali
  orcidid: 0000-0003-4238-0999
  surname: Salehzadeh
  fullname: Salehzadeh, Ali
  organization: Department of Biology, Rasht Branch, Islamic Azad University, 31567-56157 Rasht, Iran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31330954$$D View this record in MEDLINE/PubMed
BookMark eNpdkc1v1DAQxS1URD_gzgn5yCXgzzjmgLRalbKidBELZ8txJruuEnuxk0L_ewxbqpaTLc-b3xvPO0VHIQZA6CUlbzjX5O0InXc-WCmJIrxpnqATWoum0lSIowf3Y3Sa8zUhnEnFnqFjTjknWooTNG9uw7SD7DOOPb6yIVZfbLKj3QaYvMPrAeYU9-ADniJehW52gD99XWzw-gZSdf5rnyBnH8M7vMBX8BN_BrezwefxoN_51k94cbHBSxscJLyEYcjP0dPeDhle3J1n6PuH82_Lj9Xl-mK1XFxWTtRsqiQ0suulbmrZacuE1LZXCqjsJKFdSxpddD1vGRcCGHPQgmqF7iRwTZVy_AytDtwu2muzT3606dZE683fh5i2xqbyzQGMY7yVXPWa0kZIJTUFUKyRbd2RVjteWO8PrP3clr07CFOywyPo40rwO7ONN6aum8JUBfD6DpDijxnyZEafXVmHDRDnbBhTxZoKqouUHKQuxZwT9Pc2lJg_yZv_ky8trx6Od9_wL2r-G5ETrSY
CitedBy_id crossref_primary_10_1007_s00210_024_03182_9
crossref_primary_10_1007_s11033_023_08773_y
crossref_primary_10_1007_s40199_024_00512_3
crossref_primary_10_1016_j_ijbiomac_2024_130527
crossref_primary_10_1007_s12011_020_02138_3
crossref_primary_10_1007_s11033_020_05251_7
crossref_primary_10_1002_ptr_7325
crossref_primary_10_1007_s10876_021_02023_6
crossref_primary_10_3390_antiox9020149
crossref_primary_10_1080_24701556_2020_1792495
crossref_primary_10_1080_17425247_2021_1932813
crossref_primary_10_1590_0034_737x202067040009
Cites_doi 10.3390/ijms151018508
10.1186/1471-2407-7-80
10.1021/jp300585d
10.3892/mmr.2015.3266
10.1016/j.neo.2017.02.012
10.1016/j.cell.2009.11.026
10.1016/j.gde.2005.08.005
10.1242/jcs.182873
10.1074/jbc.M410670200
10.1261/rna.2183803
10.1038/onc.2017.377
10.1002/(SICI)1096-9896(199903)187:4<433::AID-PATH273>3.0.CO;2-E
10.3892/mmr.2015.3816
10.1016/S1470-2045(10)70130-3
10.1186/1756-8722-2-18
10.1002/jcb.26754
10.1186/1471-2407-8-255
10.1517/17425247.2014.924501
10.3797/scipharm.0912-18
10.1016/j.bbrc.2005.06.161
10.3748/wjg.v12.i3.354
10.1007/s10876-017-1172-6
10.4178/epih/e2015006
10.1016/S0960-9776(11)70297-1
10.18632/oncotarget.5198
10.1097/PPO.0b013e318258b771
10.1093/carcin/bgi223
10.1158/1535-7163.MCT-06-0433
ContentType Journal Article
Copyright 2019 by the authors. 2019
Copyright_xml – notice: 2019 by the authors. 2019
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3390/medicina55070388
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1648-9144
1010-660X
ExternalDocumentID oai_doaj_org_article_c23b537f9118457591ee7285b6d0b9c3
10_3390_medicina55070388
31330954
Genre Journal Article
GroupedDBID 0R~
0SF
29M
2WC
4.4
457
53G
5GY
5VS
7X7
8FI
8FJ
AACTN
AADQD
AAEDT
AAFWJ
AAIKJ
ABMAC
ABUWG
ACGFS
ADBBV
ADEZE
AFKRA
AFPKN
AFZYC
AGHFR
AHDRD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
CGR
CUY
CVF
DIK
ECM
EIF
F5P
FDB
FYUFA
GROUPED_DOAJ
HMCUK
HYE
IAO
KQ8
MODMG
NPM
O9-
OK1
PGMZT
PIMPY
RPM
UKHRP
XSB
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c462t-5e85df59865d9a2459af77e15d501db089c46f3b2344e22cebe7b49d5e39177c3
IEDL.DBID RPM
ISSN 1648-9144
1010-660X
IngestDate Tue Oct 22 15:13:25 EDT 2024
Tue Sep 17 21:21:51 EDT 2024
Fri Aug 16 01:11:36 EDT 2024
Fri Aug 23 05:00:37 EDT 2024
Sat Sep 28 08:35:04 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords miR-200 oncogene
nano-oleuropein
AGS Cancer
oleuropein
real-time PCR
K-Ras
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-5e85df59865d9a2459af77e15d501db089c46f3b2344e22cebe7b49d5e39177c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-4238-0999
0000-0003-1604-1889
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681187/
PMID 31330954
PQID 2271841419
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_c23b537f9118457591ee7285b6d0b9c3
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6681187
proquest_miscellaneous_2271841419
crossref_primary_10_3390_medicina55070388
pubmed_primary_31330954
PublicationCentury 2000
PublicationDate 20190719
PublicationDateYYYYMMDD 2019-07-19
PublicationDate_xml – month: 7
  year: 2019
  text: 20190719
  day: 19
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Medicina (Kaunas, Lithuania)
PublicationTitleAlternate Medicina (Kaunas)
PublicationYear 2019
Publisher MDPI
MDPI AG
Publisher_xml – name: MDPI
– name: MDPI AG
References Muller (ref_7) 2009; 139
Fu (ref_5) 2015; 12
Payne (ref_6) 2005; 26
Going (ref_11) 1999; 187
Abtin (ref_18) 2018; 119
Miska (ref_15) 2005; 15
Ambros (ref_14) 2003; 9
Ikediobi (ref_9) 2006; 5
Sarbishegi (ref_21) 2014; 18
Kim (ref_2) 2015; 37
Yan (ref_24) 2015; 11
Hosseinian (ref_28) 2015; 5
Choudhuri (ref_29) 2005; 280
Claes (ref_12) 2010; 11
Hobbs (ref_13) 2016; 129
Poonam (ref_26) 2012; 116
Iorio (ref_16) 2011; 3
Hamdi (ref_19) 2005; 334
Song (ref_25) 2015; 6
Crew (ref_1) 2006; 12
Khalili (ref_4) 2017; 28
Kunej (ref_17) 2012; 18
Laurent (ref_27) 2014; 11
Barbaro (ref_3) 2014; 15
ref_22
Liu (ref_23) 2016; 28
Omar (ref_20) 2010; 78
Jinesh (ref_30) 2018; 37
ref_8
David (ref_10) 2009; 2
Maleki (ref_31) 2017; 19
References_xml – volume: 15
  start-page: 18508
  year: 2014
  ident: ref_3
  article-title: Effects of the olive-Derived poly phenol Oleuropein on human health
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms151018508
  contributor:
    fullname: Barbaro
– ident: ref_22
  doi: 10.1186/1471-2407-7-80
– volume: 116
  start-page: 8834
  year: 2012
  ident: ref_26
  article-title: Bovine Serum Albumin Bioconjugated Gold Nanoparticles: Synthesis, Hemolysis, and Cytotoxicity toward Cancer Cell Lines
  publication-title: J. Phys. Chem. C
  doi: 10.1021/jp300585d
  contributor:
    fullname: Poonam
– volume: 11
  start-page: 4617
  year: 2015
  ident: ref_24
  article-title: Oleuropein induces apoptosis via activation of caspases and suppression of phosphatidylinositol 3-kinase/protein kinase B pathway in HepG2 human hepatoma cell line
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr.2015.3266
  contributor:
    fullname: Yan
– volume: 5
  start-page: 20
  year: 2015
  ident: ref_28
  article-title: Evaluation of the efficacy of magnetic nanoparticles of iron-loaded with platinum siscon breast cancer in vivo and in vitro studies
  publication-title: Mol. Biotechnol.
  contributor:
    fullname: Hosseinian
– volume: 19
  start-page: 412
  year: 2017
  ident: ref_31
  article-title: Chromosomal Instability in Gastric Cancer Biology
  publication-title: Neoplasia
  doi: 10.1016/j.neo.2017.02.012
  contributor:
    fullname: Maleki
– volume: 139
  start-page: 1327
  year: 2009
  ident: ref_7
  article-title: Mutant p53 drives invasion by promoting integrin recycling
  publication-title: Cell
  doi: 10.1016/j.cell.2009.11.026
  contributor:
    fullname: Muller
– volume: 15
  start-page: 563
  year: 2005
  ident: ref_15
  article-title: How microRNAs control cell division, differentiation and death
  publication-title: Curr. Opin. Develop.
  doi: 10.1016/j.gde.2005.08.005
  contributor:
    fullname: Miska
– volume: 129
  start-page: 1287
  year: 2016
  ident: ref_13
  article-title: RAS isoforms and mutations in cancer at a glance
  publication-title: J. Cell Sci.
  doi: 10.1242/jcs.182873
  contributor:
    fullname: Hobbs
– volume: 280
  start-page: 20059
  year: 2005
  ident: ref_29
  article-title: Curcumin selectively induces apoptosis in deregulated cyclin D1expressed cells at the G2 phase of cell cycle in a p53-dependent manner
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M410670200
  contributor:
    fullname: Choudhuri
– volume: 9
  start-page: 277
  year: 2003
  ident: ref_14
  article-title: Uniform system for microRNA annotation
  publication-title: RNA
  doi: 10.1261/rna.2183803
  contributor:
    fullname: Ambros
– volume: 37
  start-page: 839
  year: 2018
  ident: ref_30
  article-title: Molecular genetics and cellular events of K-Ras-driven tumorigenesis
  publication-title: Oncogene
  doi: 10.1038/onc.2017.377
  contributor:
    fullname: Jinesh
– volume: 187
  start-page: 433
  year: 1999
  ident: ref_11
  article-title: Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression
  publication-title: J. Pathol.
  doi: 10.1002/(SICI)1096-9896(199903)187:4<433::AID-PATH273>3.0.CO;2-E
  contributor:
    fullname: Going
– volume: 18
  start-page: 16
  year: 2014
  ident: ref_21
  article-title: Antioxidant role of oleuropein on midbrain and dopaminergic neurons of substantia in aged rats
  publication-title: Iran. Biomed. J.
  contributor:
    fullname: Sarbishegi
– volume: 12
  start-page: 3223
  year: 2015
  ident: ref_5
  article-title: Epigenetic alterations in gastric cancer
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr.2015.3816
  contributor:
    fullname: Fu
– volume: 11
  start-page: 753
  year: 2010
  ident: ref_12
  article-title: Effects of KRAS, BRAF, NRAS and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: A retrospective consortium analysis
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(10)70130-3
  contributor:
    fullname: Claes
– volume: 2
  start-page: 18
  year: 2009
  ident: ref_10
  article-title: Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy
  publication-title: J. Hematol. Oncol.
  doi: 10.1186/1756-8722-2-18
  contributor:
    fullname: David
– volume: 119
  start-page: 7151
  year: 2018
  ident: ref_18
  article-title: Simultaneous downregulation of miR-21 and miR-155 through oleuropein for breast cancer prevention and therapy
  publication-title: J. Cell Biochem.
  doi: 10.1002/jcb.26754
  contributor:
    fullname: Abtin
– ident: ref_8
  doi: 10.1186/1471-2407-8-255
– volume: 11
  start-page: 1449
  year: 2014
  ident: ref_27
  article-title: Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: Opportunities and challenges
  publication-title: Expert. Opin. Drug. Deliv.
  doi: 10.1517/17425247.2014.924501
  contributor:
    fullname: Laurent
– volume: 78
  start-page: 133
  year: 2010
  ident: ref_20
  article-title: Oleuropein in olive and its pharmacological effects
  publication-title: Sci. Pharm.
  doi: 10.3797/scipharm.0912-18
  contributor:
    fullname: Omar
– volume: 334
  start-page: 769
  year: 2005
  ident: ref_19
  article-title: Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2005.06.161
  contributor:
    fullname: Hamdi
– volume: 12
  start-page: 354
  year: 2006
  ident: ref_1
  article-title: Epidemiology of gastric cancer
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v12.i3.354
  contributor:
    fullname: Crew
– volume: 28
  start-page: 4978
  year: 2016
  ident: ref_23
  article-title: Oleuropein inhibits the proliferation and invasion of glioma cells via suppression of the AKT signaling pathway
  publication-title: Oncol. Rep.
  contributor:
    fullname: Liu
– volume: 28
  start-page: 1617
  year: 2017
  ident: ref_4
  article-title: Anticancer Properties of Phyto-Synthesized Silver Nanoparticles from Medicinal Plant Artemisia tschernieviana Besser Aerial Parts Extract Toward HT29 Human Colon Adenocarcinoma Cells
  publication-title: J. Clust. Sci.
  doi: 10.1007/s10876-017-1172-6
  contributor:
    fullname: Khalili
– volume: 37
  start-page: e2015006
  year: 2015
  ident: ref_2
  article-title: Stomach cancer incidence rates among Americans, Asian Americans and Native Asians from 1988 to 2011
  publication-title: Epidemiol. Health
  doi: 10.4178/epih/e2015006
  contributor:
    fullname: Kim
– volume: 3
  start-page: 63
  year: 2011
  ident: ref_16
  article-title: Breast cancer and microRNAs: Therapeutic impact
  publication-title: Breast
  doi: 10.1016/S0960-9776(11)70297-1
  contributor:
    fullname: Iorio
– volume: 6
  start-page: 34968
  year: 2015
  ident: ref_25
  article-title: MiR-200c inhibits breast cancer proliferation by targeting KRAS
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.5198
  contributor:
    fullname: Song
– volume: 18
  start-page: 223
  year: 2012
  ident: ref_17
  article-title: Cross Talk Between MicroRNA and Coding Cancer Genes
  publication-title: Cancer J.
  doi: 10.1097/PPO.0b013e318258b771
  contributor:
    fullname: Kunej
– volume: 26
  start-page: 2031
  year: 2005
  ident: ref_6
  article-title: Tumor suppressor genetics
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgi223
  contributor:
    fullname: Payne
– volume: 5
  start-page: 2606
  year: 2006
  ident: ref_9
  article-title: Mutation analysis of 24 known cancer genes in the NCI-60 cell line set
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-06-0433
  contributor:
    fullname: Ikediobi
SSID ssj0032572
Score 2.2982225
Snippet Human gastric adenocarcinoma (AGS) is one of the most common malignant cancers worldwide. The present study aimed to transfer oleuropein into cancer cells...
Background and objectives: Human gastric adenocarcinoma (AGS) is one of the most common malignant cancers worldwide. The present study aimed to transfer...
Background and objectives: Human gastric adenocarcinoma (AGS) is one of the most common malignant cancers worldwide. The present study aimed to transfer...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 388
SubjectTerms Adenocarcinoma - prevention & control
AGS Cancer
Cell Proliferation - drug effects
Gene Expression - drug effects
Humans
Iridoids - pharmacology
Iridoids - therapeutic use
K-Ras
miR-200 oncogene
nano-oleuropein
Nanoparticles - therapeutic use
Olea - enzymology
Olea - genetics
oleuropein
Proto-Oncogene Proteins p21(ras) - biosynthesis
Proto-Oncogene Proteins p21(ras) - blood
real-time PCR
Spectrometry, X-Ray Emission - methods
Stomach Neoplasms - prevention & control
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LatwwFBUli9BNadOX0wcqdNOFiPWype6mQ9LQMk3pNJCdkSy5MUzkMvZA8_e5sjwhEwrddGsLLHSPpHN9pXMQem-MKBTnUQ9PSiKcUURRLkleK2cboBRmdGtYfCtOz8WXC3lxx-ornglL8sBp4I5qxq3kZQOTUonoJkm9L5mStnC51XXS-cz1NplKazAHILJUlOSQ1B9NdWoTxbui_MnOJjRq9f-NYN4_J3ln4zl5jB5NjBHPUk-foAc-HKD9xVQTf4o2y-sALK5ve9w1GFbLjnw3a3NlfoV4QRGfrfz4x70NeOhwtOqoPf76Y7bEZwBjcvxnOgobPuIZhjUPL3y8Ddz2V6n9ZWvbAc8-L_E8ImSN53616p-h85Pjn_NTMpkpkFoUbCDSK-maqMYunTZMSG2asvRUOplTZ3OloV3DLeNCeMZqCG5phXbSc8joypo_R3uhC_4lwpZSbW3hG6-sENEQUEhhgHsUVDkt8gx92I5u9TtpZlSQa8RIVPcjkaFPcfhv20W16_EBYKCaMFD9CwMZercNXgWzI5Y8TPDdpq8Yg71XUEF1hl6kYN5-ikN6DgRTZKjcCfNOX3bfhPZyVOAuChVt2g__R-dfoYdAwuJNMkL1a7Q3rDf-DRCdwb4dMX0DX_j66A
  priority: 102
  providerName: Directory of Open Access Journals
Title Synthesis of Nano-Paramagnetic Oleuropein to Induce KRAS Over-Expression: A New Mechanism to Inhibit AGS Cancer Cells
URI https://www.ncbi.nlm.nih.gov/pubmed/31330954
https://search.proquest.com/docview/2271841419
https://pubmed.ncbi.nlm.nih.gov/PMC6681187
https://doaj.org/article/c23b537f9118457591ee7285b6d0b9c3
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEB6SFEIupe-qD7OFXnpQLGkfWvXmGKehxYmJG_BN7EqrRGCvgiVD--87q0eoQ0-9Siu0aD7NfrMz-w3AZ6WYkJQ6PTzOfZYr6cuQcj_IZK4LpBSq7dYwvxQXN-z7iq8OgA9nYdqi_UyXp3a9ObXlXVtbeb_JxkOd2HgxnwohXZfs8SEcIkCHEL1zvxQx2KU40cEIEay63CTF2H7cp6uV0_ByKigncEwxRkOWwfaWpVa9_1-U83Hl5F9L0fkzeNpzSDLp5vocDox9AcfzPkv-EnbL3xZ5XV3WpCoI-s_KX6it2qhb644skqu1affgS0uairjmHZkhP64nS3KFwPZnv_riWPuVTAh6QTI37nxwWW-68XelLhsy-bYkU4eZLZma9bp-BTfns5_TC79vr-BnTESNz43keeH02XmeqIjxRBVxbEKe8yDMdSATHFdQHVHGTBRlaO5YsyTnhmKMF2f0NRzZypq3QHQYJloLUxipGXMtAhlnCtmICGWesMCDL8PXTe87FY0Uow9nlPSxUTw4c5__YZzTv24vVNvbtEdBmkVUcxoX6Kolcz1GQ2PiSHIt8kAnGfXg02C8FP8XlwRR1lS7Oo0iXI1ZyMLEgzedMR9eNYDBg3jPzHtz2b-DEG01uXtIvvvvJ9_DCXIxd6DMD5MPcNRsd-Yj8p1GjxDlq3gET85ml4vrUbtrMGox_wdAbAHG
link.rule.ids 230,315,730,783,787,867,888,2109,27936,27937,31732,33757,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VIpVeeD_Mc5G4cHBiex9ecwtRS6BNW5EW5Wbt2uvWIrGr2JGAX8-sHxWJuMDVu5a9nm92Zzwz3wC8U4oJSanlw-PcZamSrvQpd71EpjpDk0I13RqmJ2Jywb7M-XwHeF8L0yTtJzofFIvloMivmtzK62Uy7PPEhmfTsRDSdske3oLbqK8e6530dgOmiMI2yIlbjBDevI1OUvTuh13AWlkWL8uDsg97FL00tDPYxsHU8Pf_zejczp384zA6vAff-mW0OSjfB-taD5JfWwyP_7zO-3C3M0_JqB1-ADumeAh70y4A_wjWs58FmoxVXpEyI7g1l-6ZWqmluixsNSQ5XZjm935ekLokti9IYsjR19GMnKLOuAc_urzb4gMZEdxgydTY0uO8Wrbzr3Kd12T0aUbGFo4rMjaLRfUYLg4PzscTt-vc4CZMBLXLjeRpZqnfeRqpgPFIZWFofJ5yz0-1JyOcl1EdUMZMECSIpFCzKOWGovsYJvQJ7BZlYZ4B0b4faS1MZqRmzHYfZJwpNHSEL9OIeQ6878UWX7cEHTE6Nlba8ba0Hfho5Xozz1JrNxfK1WXcffg4CajmNMzwFJDMti_1jQkDybVIPR0l1IG3PSpiVEUbX1GFKddVHAR40DOf-ZEDT1uU3DyqR5kD4QZ-Nt5lcwRR0dB9dyh4_t93voE7k_PpcXz8-eToBeyjyWfr1lw_egm79WptXqFZVevXjRL9BjNrIEs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFB5BkaJe2BezDhIXDo49nsVjbiE0FEraiFAp4mLN2OPWIrGj2JGAX88bL1UTcerVHsvL-97m9-Z7CL1TiglJqeXD49xlqZKuJJS7fiJTnUFIoZppDdNTcXzOvi744tqor6ZpP9H5sFiuhkV-2fRWrleJ1_eJebPpWAhpp2R76zTzbqM7oLO-6BP11ghTQGJb6AQzI4S_aCuUFDJ8rytaK8vkZblQDtGAQqYGsQbbcU4Nh___As_9_slrDmlyD_3sX6XtQ_k13NZ6mPzdY3m80bveR3e7MBWP2iUP0C1TPESDaVeIf4S28z8FhI5VXuEyw2CiS3emNmqlLgq7KxKfLU3zmz8vcF1iOx8kMfjk-2iOz0B33KPfXf9t8QGPMBhaPDV2C3Jerdr1l7nOazz6PMdjC8sNHpvlsnqMzidHP8bHbjfBwU2YCGqXG8nTzFLA8zRSAeORysLQEJ5yn6TalxGsy6gOKGMmCBJAVKhZlHJDIY0ME_oEHRRlYZ4hrAmJtBYmM1IzZqcQMs4UBDyCyDRivoPe96KL1y1RRwwJjpV4vC9xB320sr1aZym2mwPl5iLuPn6cBFRzGmbgDSSzY0yJMWEguRapr6OEOuhtj4wYVNLWWVRhym0VBwE4fEYYiRz0tEXK1a16pDko3MHQzrPsngFkNLTfHRKe3_jKN2gw-zSJv305PXmBDiHys9vXXBK9RAf1ZmteQXRV69eNHv0DP0siyw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+of+Nano-Paramagnetic+Oleuropein+to+Induce+KRAS+Over-Expression%3A+A+New+Mechanism+to+Inhibit+AGS+Cancer+Cells&rft.jtitle=Medicina+%28Kaunas%2C+Lithuania%29&rft.au=Farhad+Barzegar&rft.au=Mohammad+Zaefizadeh&rft.au=Reza+Yari&rft.au=Ali+Salehzadeh&rft.date=2019-07-19&rft.pub=MDPI+AG&rft.eissn=1010-660X&rft.volume=55&rft.issue=7&rft.spage=388&rft_id=info:doi/10.3390%2Fmedicina55070388&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_c23b537f9118457591ee7285b6d0b9c3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1648-9144&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1648-9144&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1648-9144&client=summon